Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

C.-H. Chiu · SciRah

Researcher profile · Semantic Scholar

C.-H. Chiu

Share profile

C.-H. Chiu — researcher profile on SciRah

h-index: 5
Works: 20
Citations: 107

Most-cited papers

LBA8 Nivolumab (NIVO) + chemotherapy (chemo) vs chemo in patients (pts) with EGFR-mutated metastatic non-small cell lung cancer (mNSCLC) with disease progression after EGFR tyrosine kinase inhibitors (TKIs) in CheckMate 722
T. Mok, K. Nakagawa, K. Park, Y. Ohe +16 more
2022Annals of Oncology45 citations Open access
Semantic Scholar
1325P Sunvozertinib as first-line treatment in NSCLC patients with EGFR Exon20 insertion mutations
C.-H. J. Yang, M. Wang, C.-H. Chiu, P-C. Hsu +16 more
2023Annals of Oncology18 citations Open access
Semantic Scholar
987P Sunvozertinib for NSCLC patients with EGFR exon 20 insertion mutations: Preliminary analysis of WU-KONG6, the first pivotal study
Mei Wang, C.-H. J. Yang, P. Mitchell, J. Fang +14 more
2022Annals of Oncology12 citations
Semantic Scholar
1269P Preventing infusion-related reactions with intravenous amivantamab: Updated results from SKIPPirr, a phase II study
L. Paz-Ares, A. Spira, J. Han, J-Y. Shih +16 more
2024Annals of Oncology8 citations
Semantic Scholar
OA09.04 ILLUMINATE: Efficacy and Safety of Durvalumab-Tremelimumab and Chemotherapy in EGFR Mutant NSCLC Following Progression on EGFR Inhibitors
C. Lee, B-C. Liao, S. Subramaniam, C.-H. Chiu +19 more
2023Journal of Thoracic Oncology6 citations
Semantic Scholar
MA12.08 Preventing Infusion-Related Reactions with Intravenous Amivantamab: Primary Results from SKIPPirr, a Phase 2 Study
G. Lopes, A. Spira, J. Han, J-Y. Shih +17 more
2024Journal of Thoracic Oncology5 citations
Semantic Scholar
EP08.02-029 Sunvozertinib in NSCLC Patients with EGFR Exon20 Insertion Mutations: Effect of Prior Treatment
C.-H. J. Yang, Mei Wang, P. Mitchell, J. Fang +19 more
2022Journal of Thoracic Oncology4 citations Open access
Semantic Scholar
MA13.04 Entrectinib in Patients with ROS1 Fusion-Positive (ROS1-fp) NSCLC: Updated Efficacy and Safety Analysis
Y. Fan, A. Drilon, C.-H. Chiu, D. Bowles +11 more
2022Journal of Thoracic Oncology3 citations Open access
Semantic Scholar
992P Updated analyses from the CROWN study of first-line lorlatinib vs crizotinib in Asian patients with ALK-positive non-small cell lung cancer (NSCLC)
Z. Qing, H. Kim, R. Soo, C.-H. Chiu +9 more
2022Annals of Oncology3 citations Open access
Semantic Scholar
264P Updated analysis of entrectinib in a subset of Chinese (mainland China, Hong Kong, Taiwan) patients (pts) with NTRK fusion-positive (fp) solid tumours and ROS1-fp non-small cell lung cancer (NSCLC)
S. Lu, Y. Fan, C.-H. Chiu, Y. Yu +11 more
2022Annals of Oncology2 citations Open access
Semantic Scholar
MA08.02 Zipalertinib in NSCLC Patients (Pts) With EGFR Exon 20 Insertion (Ex20Ins) Mutations Who Received Prior Amivantamab
Z. Piotrowska, D. Nguyen, V. Lee, V. Velcheti +20 more
2025Journal of Thoracic Oncology1 citations Open access
Semantic Scholar
MO12.01: Safety, Pharmacokinetics, and Preliminary Antitumor Activity of VRN110755 in EGFR-Mutated NSCLC
M.-J. Ahn, K. Lee, M. Hong, H. Kim +12 more
2026Journal of Thoracic Oncology0 citations Open access
Semantic Scholar
P2.304: Symbiotic-Lung-10: A Phase 2 Trial of PD-1/VEGF Bispecific Antibody, PF-08634404, as Monotherapy or in Combination in NSCLC
T. Cascone, H. Wakelee, L. Deng, R. Casellas +17 more
2026Journal of Thoracic Oncology0 citations
Semantic Scholar
P2.352: A Phase 1/2 Study of VRN110755 in Patients With Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC)
M.-J. Ahn, K. Lee, M. Hong, H. Kim +11 more
2026Journal of Thoracic Oncology0 citations
Semantic Scholar
2074eP Comprehensive genomic profiling of MET alterations in advanced NSCLC: Insights from a nationwide registry study in Taiwan-TCOG T1521
C.-I. Shen, Y.-H. Luo, C.-H. Chiu, N.-J. Chiang +13 more
2025Annals of Oncology0 citations Open access
Semantic Scholar
LBA12 Safety profile and anti-tumor efficacy of VRN110755, a highly selective, brain penetrant EGFR inhibitor for patients with EGFR-driven non-small cell lung cancer
M-J. Ahn, K. Lee, B. Shim, M. Hong +6 more
2025Annals of Oncology0 citations
Semantic Scholar
1279P First-line lorlatinib vs crizotinib in Asian patients with ALK+ non-small cell lung cancer (NSCLC): 5-year outcomes from the CROWN study
Y.-L. Wu, H. Kim, R. Soo, Q. Zhou +16 more
2024Annals of Oncology0 citations
Semantic Scholar
OA01.07 Sunvozertinib in NSCLC Patients with EGFR Exon20 Insertion Mutations
L. Bazhenova, Chih-Hsin J. Yang, Mei Wang, P. Mitchell +16 more
2023Journal of Thoracic Oncology0 citations
Semantic Scholar
110P Updated efficacy and safety of entrectinib in patients (pts) with NTRK fusion-positive (NTRK-fp) NSCLC
B. Cho, C.-H. Chiu, E. Massarelli, S. P. Chawla +10 more
2022Annals of Oncology0 citations Open access
Semantic Scholar
Acute Pulmonary Edema Following Ingestion of an Antiseptic Solution Containing Naphazoline: A Case Report
K. Lin, C.-H. Chiu
20110 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

T.-Y. Yang×7
Invite
T.-Y. Yang — researcher profile on SciRah
H. Kim×6
Invite
H. Kim — researcher profile on SciRah
S.-W. Kim×5
Invite
S.-W. Kim — researcher profile on SciRah
C.-H. J. Yang×4
Invite
C.-H. J. Yang — researcher profile on SciRah

×4

Invite

B. Shim — researcher profile on SciRah

Invite

K. Lee — researcher profile on SciRah

Invite

Y.-H. Luo — researcher profile on SciRah

Invite

C.-C. Lin — researcher profile on SciRah

Invite

Y.-L. Wu — researcher profile on SciRah

Invite

A. Spira — researcher profile on SciRah

Invite

Mei Wang — researcher profile on SciRah

C.-H. J. Yang×3

Invite

C.-H. J. Yang — researcher profile on SciRah